Olga V. Dymova
Olga V. Dymova has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr A. Eremenko
Petrovsky National Research Centre of Surgery, Moscow, Russia; Sechenov First Moscow State Medical University, Moscow, Russia
4 shared publications - Anna Andreevna Mikhailova
Petrovsky National Research Center of Surgery, Moscow, Russia
3 shared publications - Arkady L. Bedzhanyan
Petrovsky National Research Center of Surgery, Department of Abdominal Surgery andOncology II (Coloproctology and Uro-Gynecology), 119435, Moscow, Russia
3 shared publications - K. N. Petrenko
Petrovsky National Research Center of Surgery
3 shared publications - Yulia V. Frolova
Petrovsky National Research Centre of Surgery
3 shared publications - Boris A. Akselrod
Petrovsky National Research Center of Surgery
2 shared publications
Latest Publications
- 29 October 2025
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 14 (5) , 34-40
Efficacy and toxicity of CDK 4/6 inhibitors in real clinical practice in patients with HR+ Her2new negative metastatic breast cancer
Objective. To evaluate the efficacy and toxicity of the CDK4/6 inhibitors Palbociclib and Ribociclib in patients with HR+HER2-negative breast cancer. Material and methods. One hundred sixty-three (n=163) patients diagnosed with luminal breast cancer (BC) who received hormone-targeted therapy were included I the retrospective study. Patients were randomized into 2 groups depending on the treatment: the first group (n=79) received hormonal therapy and ribociclib, the second (n=84) received hormonal therapy and palbociclib. The primary analysis examined the objective response rate per RECIST 1.1 in each study group and the incidence and severity of adverse events using NCI CTCAE v5.0 toxicity criteria. Results. When analyzing objective responses according to RECIST 1.1, complete responses (CR) were not observed in groups, partial responses (PR) were detected in 15% (n=11) of patients in the ribociclib group and in 15% (n=13) — in the palbociclib group (p=0.7799), stabilization (SD) — in 43% (n=34) of cases in group 1 and in 48% (n=40) of cases in group 2 (p=0.5574); progression (PD) — in 25% (n=20) versus 15% (n=13) (p=0.1194), respectively. Leukopenia was observed in 8.9% (n=7) patients in the ribociclib group and in 26.2% (n=22) patients in the palbociclib group (p=0.0088). The incidence of neutropenia in the palbociclib group was 27.4% (n=23). The use of ribociclib was associated with a more frequent development of hepatotoxicity: 17.7% (n=14) versus 3.6% (n=3) of patients receiving ribociclib and palbociclib, respectively. There was no difference between the groups in the frequency of anemia and asthenia. Conclusion. The use of CDK 4/6 inhibitors in the treatment of patients with luminal Her2-negative breast cancer is effective, but the appointment of targeted therapy is associated with the development of adverse effects, which can affect the choice of drug depending on the comorbidity and initial clinical and instrumental parameters.
- 29 October 2025
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 14 (5) , 34-40
Efficacy and toxicity of CDK 4/6 inhibitors in real clinical practice in patients with HR+ Her2new negative metastatic breast cancer
Objective. To evaluate the efficacy and toxicity of the CDK4/6 inhibitors Palbociclib and Ribociclib in patients with HR+HER2-negative breast cancer. Material and methods. One hundred sixty-three (n=163) patients diagnosed with luminal breast cancer (BC) who received hormone-targeted therapy were included I the retrospective study. Patients were randomized into 2 groups depending on the treatment: the first group (n=79) received hormonal therapy and ribociclib, the second (n=84) received hormonal therapy and palbociclib. The primary analysis examined the objective response rate per RECIST 1.1 in each study group and the incidence and severity of adverse events using NCI CTCAE v5.0 toxicity criteria. Results. When analyzing objective responses according to RECIST 1.1, complete responses (CR) were not observed in groups, partial responses (PR) were detected in 15% (n=11) of patients in the ribociclib group and in 15% (n=13) — in the palbociclib group (p=0.7799), stabilization (SD) — in 43% (n=34) of cases in group 1 and in 48% (n=40) of cases in group 2 (p=0.5574); progression (PD) — in 25% (n=20) versus 15% (n=13) (p=0.1194), respectively. Leukopenia was observed in 8.9% (n=7) patients in the ribociclib group and in 26.2% (n=22) patients in the palbociclib group (p=0.0088). The incidence of neutropenia in the palbociclib group was 27.4% (n=23). The use of ribociclib was associated with a more frequent development of hepatotoxicity: 17.7% (n=14) versus 3.6% (n=3) of patients receiving ribociclib and palbociclib, respectively. There was no difference between the groups in the frequency of anemia and asthenia. Conclusion. The use of CDK 4/6 inhibitors in the treatment of patients with luminal Her2-negative breast cancer is effective, but the appointment of targeted therapy is associated with the development of adverse effects, which can affect the choice of drug depending on the comorbidity and initial clinical and instrumental parameters.
- Open Access
- 20 October 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (5) , 21-31
Comparative evaluation of the analgesic, opioid-sparing, and anti-inflammatory effects of multimodal regimens based on paracetamol and a fixed combination of diclofenac with orphenadrine in the early postoperative period in cardiac surgery patients
Introduction. The surgical stress response in patients undergoing cardiac surgery is the primary cause of systemic inflammatory response syndrome (SIRS) development and requires investigation of methods for its modulation, including the development of optimal postoperative analgesia regimens. The objective was to conduct a comparative evaluation of the analgesic, opioid-sparing and anti-inflammatory effects of paracetamol and a fixed combination of diclofenac with orphenadrine in the early postoperative period in cardiac surgery patients. Materials and methods . The study included 60 patients undergoing cardiopulmonary bypass surgery. The group 1 (group N) included 30 patients who received Neodolpasse infusion; intravenous paracetamol was administrated to 30 patients in group 2 (group P). Both groups received patient-controlledanalgesia (PCA) with morphine. The intensity of the pain syndrome was assessed with a 100 mm visual-analog scale (VAS). The daily opioid requirement was determined, and blood samples for proinflammatory markers were collected; interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP). These samples were assessed before analgesia and at 24 and 48 hours post-procedure. Results. With initially high VAS scores observed throughout the study, group N demonstrated a significantly more pronounced analgesic effect compared to group P. The requirement for additional morphine bolus infusions in group N was 2.7 times lower than in group P. Adverse events characteristics of the opioid analgesic morphine were significantly more frequent in group P. Cytokine analysis at 6 hours postoperatively revealed a 30-fold or greater increase in IL-6 levels. During the second phase, only group N demonstrated a trend toward IL-6 reduction. A significant increase in C-reactive protein (CRP) was observed only by the end of the first 24 hours, averaging 93 [68–129.5] mg/L in group N and 110.3 [82.7–151.6] mg/L in group P. By 48 hours, group N (fixed combination group) showed statistically significant CRP reduction, while group P maintained elevated CRP levels. No significant IL-8 elevation was detected, and TNF-α and IL-1β levels remained within normal reference throughout the observation period. Conclusion. The fixed combination of nonsteroidal anti-inflammatory drug (NSAID) diclofenac and centrally acting muscle relaxant orphenadrine demonstrates clinical advantages over intravenous paracetamol, providing superior analgesic efficacy, reducing PCA morphine requirements, and attenuating systemic response manifestations.
- 20 October 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (5) , 21-31
Open AccessComparative evaluation of the analgesic, opioid-sparing, and anti-inflammatory effects of multimodal regimens based on paracetamol and a fixed combination of diclofenac with orphenadrine in the early postoperative period in cardiac surgery patients
Introduction. The surgical stress response in patients undergoing cardiac surgery is the primary cause of systemic inflammatory response syndrome (SIRS) development and requires investigation of methods for its modulation, including the development of optimal postoperative analgesia regimens. The objective was to conduct a comparative evaluation of the analgesic, opioid-sparing and anti-inflammatory effects of paracetamol and a fixed combination of diclofenac with orphenadrine in the early postoperative period in cardiac surgery patients. Materials and methods . The study included 60 patients undergoing cardiopulmonary bypass surgery. The group 1 (group N) included 30 patients who received Neodolpasse infusion; intravenous paracetamol was administrated to 30 patients in group 2 (group P). Both groups received patient-controlledanalgesia (PCA) with morphine. The intensity of the pain syndrome was assessed with a 100 mm visual-analog scale (VAS). The daily opioid requirement was determined, and blood samples for proinflammatory markers were collected; interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP). These samples were assessed before analgesia and at 24 and 48 hours post-procedure. Results. With initially high VAS scores observed throughout the study, group N demonstrated a significantly more pronounced analgesic effect compared to group P. The requirement for additional morphine bolus infusions in group N was 2.7 times lower than in group P. Adverse events characteristics of the opioid analgesic morphine were significantly more frequent in group P. Cytokine analysis at 6 hours postoperatively revealed a 30-fold or greater increase in IL-6 levels. During the second phase, only group N demonstrated a trend toward IL-6 reduction. A significant increase in C-reactive protein (CRP) was observed only by the end of the first 24 hours, averaging 93 [68–129.5] mg/L in group N and 110.3 [82.7–151.6] mg/L in group P. By 48 hours, group N (fixed combination group) showed statistically significant CRP reduction, while group P maintained elevated CRP levels. No significant IL-8 elevation was detected, and TNF-α and IL-1β levels remained within normal reference throughout the observation period. Conclusion. The fixed combination of nonsteroidal anti-inflammatory drug (NSAID) diclofenac and centrally acting muscle relaxant orphenadrine demonstrates clinical advantages over intravenous paracetamol, providing superior analgesic efficacy, reducing PCA morphine requirements, and attenuating systemic response manifestations.
- 19 September 2024
- Published by Media Sphere Publishing Group in Regenerative biotechnologies, preventive, digital and predictive medicine
- Vol. 1 (3)
Modern scientific and practical approaches to searching for biomarkers of aging
This review summarizes data on mean life expectancy in Russia. Increased life expectancy is due to improved quality of medical care and more responsible attitude to own health. The last one is confirmed by improved nutrition, reduced alcohol consumption and increased number of people involved in sports. To date, there are many cellular and molecular signs of aging. The main ones are genome stability, telomere shortening, epigenetic alterations, impaired proteostasis and nutrient recognition, mitochondrial dysfunction, depletion of stem cell pool and changes of intercellular interactions, extracellular matrix rigidity, as well as activation of retrotransposons and chronic inflammation. We analyze the main theories of aging and classification of aging biomarkers. The relevance of preventing premature aging and treating age-related diseases is emphasized. Moreover, these objectives are a priority considering the onset of new national project “Long and Active Life” in 2025. The main goal will be to achieve new indicators of longevity of citizens.
- 19 September 2024
- Published by Media Sphere Publishing Group in Regenerative biotechnologies, preventive, digital and predictive medicine
- Vol. 1 (3)
Modern scientific and practical approaches to searching for biomarkers of aging
This review summarizes data on mean life expectancy in Russia. Increased life expectancy is due to improved quality of medical care and more responsible attitude to own health. The last one is confirmed by improved nutrition, reduced alcohol consumption and increased number of people involved in sports. To date, there are many cellular and molecular signs of aging. The main ones are genome stability, telomere shortening, epigenetic alterations, impaired proteostasis and nutrient recognition, mitochondrial dysfunction, depletion of stem cell pool and changes of intercellular interactions, extracellular matrix rigidity, as well as activation of retrotransposons and chronic inflammation. We analyze the main theories of aging and classification of aging biomarkers. The relevance of preventing premature aging and treating age-related diseases is emphasized. Moreover, these objectives are a priority considering the onset of new national project “Long and Active Life” in 2025. The main goal will be to achieve new indicators of longevity of citizens.
- Open Access
- 27 August 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 21 (4) , 85-91
Clinical case of effective treatment of invasive mycosis caused by polyresistant strain of Candida auris
The objective was to demonstrate a clinical case of effective treatment of a patient with invasive mycosis caused by Candida auris with drug resistance to antifungal drugs by a combination of micafungin and amphotericin B lipid complex.Materials and methods. International databases such as MEDLINE, EMBASE, Web of Science and Scopus until 2023 were used for the analysis.Results. We have demonstrated the effective case of treatment of invasive candidiasis caused by the polyresistent pathogen Candida auris with the combination of micafungin and amphotericin B in the patient who underwent mitral valve replacement, which was complicated by acute aortic dissection, acute thrombosis of the superior mesenteric artery, septic shock and a number of other nosocomial infections.Conclusion. Due to the high resistance of Candida auris to all antifungal drugs currently existing in the world, the combination of several antifungal drugs is an advantage over monotherapy. However, given the lack of approved standards and guidelines for the treatment of patients with this infection, and insufficient clinical experience in the management of such patients, further search for effective treatment regimens for infections caused by Candida auris and the development of new antifungal agents that can overcome the resistance of this pathogen are necessary.
- 27 August 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 21 (4) , 85-91
Open AccessClinical case of effective treatment of invasive mycosis caused by polyresistant strain of Candida auris
The objective was to demonstrate a clinical case of effective treatment of a patient with invasive mycosis caused by Candida auris with drug resistance to antifungal drugs by a combination of micafungin and amphotericin B lipid complex.Materials and methods. International databases such as MEDLINE, EMBASE, Web of Science and Scopus until 2023 were used for the analysis.Results. We have demonstrated the effective case of treatment of invasive candidiasis caused by the polyresistent pathogen Candida auris with the combination of micafungin and amphotericin B in the patient who underwent mitral valve replacement, which was complicated by acute aortic dissection, acute thrombosis of the superior mesenteric artery, septic shock and a number of other nosocomial infections.Conclusion. Due to the high resistance of Candida auris to all antifungal drugs currently existing in the world, the combination of several antifungal drugs is an advantage over monotherapy. However, given the lack of approved standards and guidelines for the treatment of patients with this infection, and insufficient clinical experience in the management of such patients, further search for effective treatment regimens for infections caused by Candida auris and the development of new antifungal agents that can overcome the resistance of this pathogen are necessary.
- Open Access
- 14 June 2024
- Published by Publishing House ABV Press in MD-Onco
- Vol. 4 (2) , 87-92
Modulation of the intestinal microbiota as a new strategy for the prevention and treatment of comorbid chronic cardiovascular diseases and colorectal cancer in one patient. Review
To date, the etiological causes of adverse outcomes associated with cardiovascular diseases and concomitant colorectal cancer in one patient, especially over 60 years of age, are multifactorial: from undiagnosed timely above-mentioned pathological conditions to poor adherence to treatment. It is a multi-level approach that is the future guarantee of reducing the burden on public health as a result of these most common nosologies.The aim of the work is to evaluate discussions between different experts with an analysis of fundamental and clinical studies based on world literature in the search for new prospects for the treatment of patients with cardiovascular pathology and comorbid colorectal cancer based on the composition and function of the intestinal microbiota.A literature search was conducted in the PubMed electronic database using the keywords: intestinal microbiota, cardio-oncology, oncosurgery, colorectal cancer, cardiovascular diseases. Additional sources were identified through literature cross-referencing. Search period: 2023.The gut microbiome is a potential marker for better risk stratification of cardiovascular diseases, colorectal cancer, and prediction of shortand long-term major adverse cardiovascular and cancer events. To develop clear recommendations and conclusions, additional research is required.
- 14 June 2024
- Published by Publishing House ABV Press in MD-Onco
- Vol. 4 (2) , 87-92
Open AccessModulation of the intestinal microbiota as a new strategy for the prevention and treatment of comorbid chronic cardiovascular diseases and colorectal cancer in one patient. Review
To date, the etiological causes of adverse outcomes associated with cardiovascular diseases and concomitant colorectal cancer in one patient, especially over 60 years of age, are multifactorial: from undiagnosed timely above-mentioned pathological conditions to poor adherence to treatment. It is a multi-level approach that is the future guarantee of reducing the burden on public health as a result of these most common nosologies.The aim of the work is to evaluate discussions between different experts with an analysis of fundamental and clinical studies based on world literature in the search for new prospects for the treatment of patients with cardiovascular pathology and comorbid colorectal cancer based on the composition and function of the intestinal microbiota.A literature search was conducted in the PubMed electronic database using the keywords: intestinal microbiota, cardio-oncology, oncosurgery, colorectal cancer, cardiovascular diseases. Additional sources were identified through literature cross-referencing. Search period: 2023.The gut microbiome is a potential marker for better risk stratification of cardiovascular diseases, colorectal cancer, and prediction of shortand long-term major adverse cardiovascular and cancer events. To develop clear recommendations and conclusions, additional research is required.
- 31 May 2024
- Published by Media Sphere Publishing Group in Regenerative biotechnologies, preventive, digital and predictive medicine
- Vol. 1 (1)
Influence of intestinal microbiota on cardiovascular atherosclerotic diseases and colorectal cancer in elderly patients
Objective. To evaluate the role of intestinal microbiota on development of cardiovascular atherosclerotic diseases and colorectal cancer in an elderly patient. Material and methods. We present stage-by-stage treatment of multifocal aortic lesions and colorectal cancer in a patient over 75 years old with preoperative analysis of intestinal microbiota. Results. Our results regarding 16S rRNA sequencing confirmed the need for vigilance in relation to inflammatory processes and neoplasms in the intestine and cardiovascular diseases (lipometabolism, metabolic syndrome and obesity). Conclusion. This case convincingly demonstrates the feasibility and necessity of intestinal microbiota analysis for differential diagnosis of intestinal metabolites responsible for development and progression of cardiovascular diseases and colorectal cancer in an elderly patient.
- 31 May 2024
- Published by Media Sphere Publishing Group in Regenerative biotechnologies, preventive, digital and predictive medicine
- Vol. 1 (1)
Influence of intestinal microbiota on cardiovascular atherosclerotic diseases and colorectal cancer in elderly patients
Objective. To evaluate the role of intestinal microbiota on development of cardiovascular atherosclerotic diseases and colorectal cancer in an elderly patient. Material and methods. We present stage-by-stage treatment of multifocal aortic lesions and colorectal cancer in a patient over 75 years old with preoperative analysis of intestinal microbiota. Results. Our results regarding 16S rRNA sequencing confirmed the need for vigilance in relation to inflammatory processes and neoplasms in the intestine and cardiovascular diseases (lipometabolism, metabolic syndrome and obesity). Conclusion. This case convincingly demonstrates the feasibility and necessity of intestinal microbiota analysis for differential diagnosis of intestinal metabolites responsible for development and progression of cardiovascular diseases and colorectal cancer in an elderly patient.
- 23 March 2023
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 16 (2)
Major risk factors of cardiovascular complications at all stages of surgical treatment of elderly and senile patients with colorectal cancer and concomitant cardiovascular diseases
Objective. To analyze the major risk factors of cardiovascular complications at all stages of surgical treatment of elderly and senile patients with colorectal cancer and concomitant cardiovascular diseases. Material and methods. We enrolled 97 patients (51 men and 46 women) over 60 years old with comorbid cardiovascular diseases between January 2018 and September 2022. All ones underwent surgery for colorectal cancer including fast track postoperative technologies. Mean age of patients was 72.8±6.8 years. Results. Complicated postoperative period depended on NYHA class of heart failure, body mass index, heart valve disease and ASA class. Complicated postoperative period significantly lengthened ICU- and hospital-stay. Conclusion. Careful postoperative cardiac monitoring of elderly patients with colorectal cancer indicates potential need for aggressive treatment of pre-existing comorbid diseases.
- 23 March 2023
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 16 (2)
Major risk factors of cardiovascular complications at all stages of surgical treatment of elderly and senile patients with colorectal cancer and concomitant cardiovascular diseases
Objective. To analyze the major risk factors of cardiovascular complications at all stages of surgical treatment of elderly and senile patients with colorectal cancer and concomitant cardiovascular diseases. Material and methods. We enrolled 97 patients (51 men and 46 women) over 60 years old with comorbid cardiovascular diseases between January 2018 and September 2022. All ones underwent surgery for colorectal cancer including fast track postoperative technologies. Mean age of patients was 72.8±6.8 years. Results. Complicated postoperative period depended on NYHA class of heart failure, body mass index, heart valve disease and ASA class. Complicated postoperative period significantly lengthened ICU- and hospital-stay. Conclusion. Careful postoperative cardiac monitoring of elderly patients with colorectal cancer indicates potential need for aggressive treatment of pre-existing comorbid diseases.
- 1 January 2023
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 16 (6)
Del Nido cardioplegia in patients with severe myocardial hypertrophy
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить адекватность защиты миокарда в периоде интраоперационной аноксии с помощью кардиоплегии по Del Nido у больных с выраженной гипертрофией миокарда в исходе тяжелого аортального стеноза и обструктивной гипертрофической кардиомиопатии (ГКМП). МАТЕРИАЛ И МЕТОДЫ За период с января 2020 по июль 2023 г. в исследование были включены 225 пациентов с разной степенью гипертрофии миокарда, которым было проведено кардиохирургическое вмешательство: 150 (66,7%) пациентам выполнена септальная миоэктомия по поводу ГКМП, 75 (33,3%) — протезирование аортального клапана ввиду тяжелого склеродегенеративного аортального стеноза. У всех больных для интраоперационной защиты миокарда использовали кардиоплегический раствор Del Nido. Оценивали периоперационные осложнения, летальность, длительность госпитализации, гистологические данные и маркеры повреждения миокарда. РЕЗУЛЬТАТЫ Среднее время аноксии миокарда составило 63,5±15,9 мин (44—90), время искусственного кровообращения (ИК) — 85,1±12,3 мин (65—105). Ранней послеоперационной летальности и случаев острой сердечной недостаточности с потребностью в механической поддержке кровообращения не было. Максимальные концентрации тропонина I наблюдали через 2 ч после ИК — 2,5±1,5 нг/мл. Через 12 и 24 ч после поступления в отделение интенсивной терапии концентрация снижалась до 1,7±1,1 нг/мл. Среднее время пребывания в отделении интенсивной терапии составило 1,5±0,8 сут, в стационаре после операции — 6,9±1,5 сут. ВЫВОД Кардиоплегия Del Nido может успешно применяться у пациентов с разной степенью гипертрофии миокарда в исходе клапанных пороков и гипертрофической кардиомиопатии.
- 1 January 2023
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 16 (6)
Del Nido cardioplegia in patients with severe myocardial hypertrophy
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить адекватность защиты миокарда в периоде интраоперационной аноксии с помощью кардиоплегии по Del Nido у больных с выраженной гипертрофией миокарда в исходе тяжелого аортального стеноза и обструктивной гипертрофической кардиомиопатии (ГКМП). МАТЕРИАЛ И МЕТОДЫ За период с января 2020 по июль 2023 г. в исследование были включены 225 пациентов с разной степенью гипертрофии миокарда, которым было проведено кардиохирургическое вмешательство: 150 (66,7%) пациентам выполнена септальная миоэктомия по поводу ГКМП, 75 (33,3%) — протезирование аортального клапана ввиду тяжелого склеродегенеративного аортального стеноза. У всех больных для интраоперационной защиты миокарда использовали кардиоплегический раствор Del Nido. Оценивали периоперационные осложнения, летальность, длительность госпитализации, гистологические данные и маркеры повреждения миокарда. РЕЗУЛЬТАТЫ Среднее время аноксии миокарда составило 63,5±15,9 мин (44—90), время искусственного кровообращения (ИК) — 85,1±12,3 мин (65—105). Ранней послеоперационной летальности и случаев острой сердечной недостаточности с потребностью в механической поддержке кровообращения не было. Максимальные концентрации тропонина I наблюдали через 2 ч после ИК — 2,5±1,5 нг/мл. Через 12 и 24 ч после поступления в отделение интенсивной терапии концентрация снижалась до 1,7±1,1 нг/мл. Среднее время пребывания в отделении интенсивной терапии составило 1,5±0,8 сут, в стационаре после операции — 6,9±1,5 сут. ВЫВОД Кардиоплегия Del Nido может успешно применяться у пациентов с разной степенью гипертрофии миокарда в исходе клапанных пороков и гипертрофической кардиомиопатии.
- Open Access
- 24 December 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 19 (6) , 72-77
A Clinical Case of Effective Treatment of Pneumonia Caused by Polyresistant Strains with the Use of Inhalation Colistimethate Sodium
Клинический случай эффективного лечения пневмонии, вызванной полирезистентными штаммами, с использованием ингаляционного колистиметата натрия
- 24 December 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 19 (6) , 72-77
Open AccessA Clinical Case of Effective Treatment of Pneumonia Caused by Polyresistant Strains with the Use of Inhalation Colistimethate Sodium
Клинический случай эффективного лечения пневмонии, вызванной полирезистентными штаммами, с использованием ингаляционного колистиметата натрия
- 1 January 2022
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 10 (4)
Emergency replacement of the thoracoabdominal aorta Extent II without cardiopulmonary bypass in a patient with Hageman’s disease
Экстренное протезирование торакоабдоминального отдела аорты Extent II без искусственного кровообращения у пациента с болезнью Хагемана
- 1 January 2022
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 10 (4)
Emergency replacement of the thoracoabdominal aorta Extent II without cardiopulmonary bypass in a patient with Hageman’s disease
Экстренное протезирование торакоабдоминального отдела аорты Extent II без искусственного кровообращения у пациента с болезнью Хагемана